Annual Financials for Gilead Sciences Inc.
Operating Activities
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Net Income before Extraordinaries |
4.64B | 5.46B | 5.36B | 89M | 6.2B | |
Net Income Growth |
- | 17.57% | -1.76% | -98.34% | 6,867.42% | |
Depreciation, Depletion & Amortization |
1.29B | 1.43B | 1.4B | 1.48B | 2.05B | |
Depreciation and Depletion |
233M | 226M | 255M | 288M | 329M | |
Amortization of Intangible Assets |
1.05B | 1.2B | 1.15B | 1.19B | 1.72B | |
Deferred Taxes & Investment Tax Credit |
(82M) | 289M | (2.1B) | (214M) | (116M) | |
Deferred Taxes |
(82M) | 289M | (2.1B) | (214M) | (116M) | |
Investment Tax Credit |
- | - | - | - | - | |
Other Funds |
942M | 2.16B | 5.27B | 8.45B | 2.76B | |
Funds from Operations |
6.79B | 9.34B | 9.94B | 9.81B | 10.9B | |
Extraordinaries |
- | - | - | - | - | |
Changes in Working Capital |
5.11B | (939M) | (798M) | (1.64B) | 489M | |
Receivables |
754M | 480M | (218M) | (1.17B) | 313M | |
Accounts Payable |
(430M) | (39M) | (61M) | 80M | (118M) | |
Other Assets/Liabilities |
358M | 903M | (307M) | (214M) | (42M) | |
Net Operating Cash Flow |
11.9B | 8.4B | 9.14B | 8.17B | 11.38B | |
Net Operating Cash Flow Growth |
- | -29.40% | 8.86% | -10.67% | 39.37% | |
Net Operating Cash Flow / Sales |
45.53% | 37.81% | 40.96% | 33.15% | 41.59% | |
Investing Activities
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Capital Expenditures |
(590M) | (924M) | (825M) | (650M) | (579M) | |
Capital Expenditures (Fixed Assets) |
(590M) | (924M) | (825M) | (650M) | (579M) | |
Capital Expenditures (Other Assets) |
- | - | - | - | - | |
Capital Expenditures Growth |
- | -56.61% | 10.71% | 21.21% | 10.92% | |
Capital Expenditures / Sales |
-2.26% | -4.16% | -3.70% | -2.64% | -2.12% | |
Net Assets from Acquisitions |
(10.43B) | - | - | (25.74B) | (1.4B) | |
Sale of Fixed Assets & Businesses |
- | - | - | - | - | |
Purchase/Sale of Investments |
(5.05B) | 15.28B | (2.31B) | 11.95B | (987M) | |
Purchase of Investments |
(23.31B) | (10.58B) | (32.23B) | (20.77B) | (3.9B) | |
Sale/Maturity of Investments |
18.26B | 25.86B | 29.92B | 32.72B | 2.91B | |
Other Uses |
- | - | (4.69B) | (171M) | (163M) | |
Other Sources |
- | - | - | - | - | |
Net Investing Cash Flow |
(16.07B) | 14.36B | (7.82B) | (14.62B) | (3.13B) | |
Net Investing Cash Flow Growth |
- | 189.33% | -154.45% | -86.96% | 78.58% | |
Net Investing Cash Flow / Sales |
-61.48% | 64.62% | -35.02% | -59.31% | -11.44% | |
Financing Activities
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Cash Dividends Paid - Total |
(2.73B) | (2.97B) | (3.22B) | (3.45B) | (3.61B) | |
Common Dividends |
(2.73B) | (2.97B) | (3.22B) | (3.45B) | (3.61B) | |
Preferred Dividends |
- | - | - | - | - | |
Change in Capital Stock |
(720M) | (2.61B) | (1.54B) | (1.33B) | (377M) | |
Repurchase of Common & Preferred Stk. |
(954M) | (2.9B) | (1.75B) | (1.58B) | (546M) | |
Sale of Common & Preferred Stock |
234M | 289M | 209M | 256M | 169M | |
Proceeds from Stock Options |
234M | 289M | 209M | 256M | 169M | |
Other Proceeds from Sale of Stock |
- | - | - | - | - | |
Issuance/Reduction of Debt, Net |
7.17B | (6.25B) | (2.75B) | 5.68B | (4.75B) | |
Change in Current Debt |
- | - | - | - | - | |
Change in Long-Term Debt |
7.17B | (6.25B) | (2.75B) | 5.68B | - | |
Issuance of Long-Term Debt |
8.99B | - | - | 8.18B | - | |
Reduction in Long-Term Debt |
(1.81B) | (6.25B) | (2.75B) | (2.5B) | (4.75B) | |
Other Funds |
(330M) | (486M) | (122M) | (138M) | (145M) | |
Other Uses |
(330M) | (486M) | (122M) | (138M) | (145M) | |
Other Sources |
- | - | - | - | - | |
Net Financing Cash Flow |
3.39B | (12.32B) | (7.63B) | 770M | (8.88B) | |
Net Financing Cash Flow Growth |
- | -463.04% | 38.03% | 110.09% | -1,252.86% | |
Net Financing Cash Flow / Sales |
12.98% | -55.45% | -34.20% | 3.12% | -32.43% | |
Exchange Rate Effect |
137M | (85M) | (2M) | 43M | (35M) | |
Miscellaneous Funds |
- | - | - | - | - | |
Net Change in Cash |
(641M) | 10.35B | (6.31B) | (5.63B) | (659M) | |
Free Cash Flow |
11.31B | 7.48B | 8.32B | 7.52B | 10.81B | |
Free Cash Flow Growth |
- | -33.89% | 11.28% | -9.63% | 43.72% | |
Free Cash Flow Yield |
- | - | - | - | 7.86% | NA |